– Sulzer at a glance – Our key figures

Our key figures

Order intake by division

2021

Order intake by region

2021

Key figures

millions of CHF

 

2021

 

2020 1)

 

Change in +/–%

 

+/–% adjusted 2)

 

+/–% organic 3)

Order intake from continuing operations

 

3’167.6

 

3’049.2

 

3.9

 

3.6

 

0.9

Order intake gross margin from continuing operations

 

33.1%

 

32.6%

 

 

 

 

 

 

Order backlog from continuing operations as of December 31

 

1’724.1

 

1’676.8

 

2.8

 

 

 

 

Sales from continuing operations

 

3’155.3

 

2’967.8

 

6.3

 

6.0

 

3.5

EBIT from continuing operations

 

221.8

 

132.5

 

67.4

 

 

 

 

Operational profit from continuing operations

 

293.3

 

255.0

 

15.1

 

14.1

 

10.9

Operational profitability from continuing operations

 

9.3%

 

8.6%

 

 

 

 

 

 

Operational ROCEA from continuing operations

 

22.7%

 

21.3%

 

 

 

 

 

 

Core net income from continuing operations

 

195.3

 

165.6

 

17.9

 

 

 

 

Net income from continuing operations

 

140.7

 

71.5

 

96.7

 

 

 

 

Basic earnings per share from continuing operations (in CHF)

 

4.10

 

2.00

 

104.9

 

 

 

 

Free cash flow (FCF)

 

238.7

 

272.1

 

–12.3

 

 

 

 

Net debt as of December 31

 

66.8

 

414.5

 

–83.9

 

 

 

 

Employees (number of full-time equivalents) from continuing operations as of December 31

 

13’816

 

13’197

 

4.7

 

 

 

 

1) Comparative information has been re-presented due to discontinued operations (details are described in note 7 to the consolidated financial statements).

2) Adjusted for currency effects.

3) Adjusted for acquisition and currency effects.

13’800
employees from all over the world work at Sulzer.
180
production and service locations spreads across the globe.
CHF
3.2
billion Sales generated in 2021 from continuing operations.

Stock market information

 

 

2021

 

2020

 

2019

 

2018

 

2017

Registered share (in CHF)

 

 

 

 

 

 

 

 

 

 

– high

 

144.40

 

110.50

 

113.40

 

137.50

 

129.90

– low 1)

 

92.35

 

40.12

 

75.15

 

76.30

 

102.30

– year-end 1)

 

134.85

 

93.10

 

108.00

 

78.05

 

118.20

 

 

 

 

 

 

 

 

 

 

 

Market capitalization as of December 31 1)

 

 

 

 

 

 

 

 

 

 

– number of shares outstanding

 

33’727’637

 

33’835’903

 

34’021’446

 

33’950’499

 

34’043’093

– in millions of CHF

 

4’548

 

3’150

 

3’674

 

2’650

 

4’024

– in percentage of equity

 

357%

 

224%

 

232%

 

163%

 

240%

 

 

 

 

 

 

 

 

 

 

 

P/E ratio as of December 31

 

3.2x

 

37.8x

 

23.9x

 

21.9x

 

48.4x

Dividend yield as of December 31

 

2.6%

 

4.3%

 

3.7%

 

4.5%

 

3.0%

1) Including CHF 45.00 per share from medmix spin-off.

Data per share

CHF

 

2021

 

2020

 

2019

 

2018

 

2017

Net income attributable to a shareholder of Sulzer Ltd

 

41.93

 

2.46

 

4.52

 

3.56

 

2.44

Change from prior year

 

1’603%

 

–46%

 

27%

 

46%

 

41%

Equity attributable to a shareholder of Sulzer Ltd

 

37.80

 

41.50

 

46.50

 

48.00

 

49.40

Ordinary dividend

 

3.50 1)

 

4.00

 

4.00

 

3.50

 

3.50

Payout ratio

 

8%

 

163%

 

88%

 

98%

 

143%

Average number of shares outstanding

 

33’788’006

 

33’970’141

 

34’026’442

 

31’934’459

 

34’084’133

1) Proposal to the Annual General Meeting.

Shareholder structure as of December 31, 2021

Number of shares

 

Number of shareholders

 

Shareholding

1–100

 

4’170

 

0.7%

101–1’000

 

4’783

 

4.6%

1’001–10’000

 

580

 

4.6%

10’001–100’000

 

95

 

8.2%

More than 100’000

 

11

 

58.7%

Total registered shareholders and shares (excluding treasury shares Sulzer Ltd)

 

9’639

 

76.7%